EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer

Lucia Maria Procopciuc iD, Adrina Corina Hangan iD, Roxana Liana Lucaciu iD

Nutrients · 2026

DOI: 10.3390/nu18101591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Lucia Maria Procopciuc und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Synbiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a multifactorial disease arising from dynamic interactions between gut microbiota, inflammatory processes, metabolic reprogramming, and dysregulated host signaling pathways. Increasing evidence highlights the potential of synbiotics—combinations of probiotics and prebiotics—as promising modulators of these processes. This review explores the mechanisms by which synbiotics influence CRC development and progression, integrating data from preclinical and clinical studies. Synbiotics exert beneficial effects by restoring microbial balance, enhancing the production of short-chain fatty acids (SCFAs), strengthening intestinal barrier integrity, and reducing chronic inflammation and oxidative stress. These functional changes converge on key molecular pathways, including Wnt/β-catenin, NF-κB, and PI3K/Akt/mTOR, which regulate tumor cell proliferation, survival, and immune responses. Preclinical studies consistently demonstrate anti-tumor effects, including reduced tumor growth, increased apoptosis, and modulation of the tumor microenvironment. Clinical evidence suggests that synbiotics may improve postoperative outcomes, reduce chemotherapy-related toxicity, and positively influence microbiome composition, although results remain heterogeneous. Emerging approaches focusing on microbiome profiling and personalized synbiotic interventions offer new opportunities for precision medicine in CRC. Overall, synbiotics represent a promising adjunctive strategy in colorectal cancer management, with potential to enhance therapeutic efficacy and improve patient outcomes. Further large-scale clinical studies are needed to validate their long-term benefits and establish standardized treatment protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsSynbioticsGastrointestinal MicrobiomeHumansAnimalsProbioticsTumor MicroenvironmentSignal TransductionPrebiotics

Stichwörter der Autor:innen

colorectal cancermicrobiomesynbiotics

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Medical Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
  • Department of Inorganic Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Pharmaceutical Biochemistry and Clinical Laboratory, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

ORCID-Profile: Lucia Maria Procopciuc, Adrina Corina Hangan, Roxana Liana Lucaciu

Zitieren

APA

Procopciuc, L. M., Hangan, A. C., & Lucaciu, R. L. (2026). Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer. Nutrients. https://doi.org/10.3390/nu18101591

Vancouver

Procopciuc LM, Hangan AC, Lucaciu RL. Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer. Nutrients. 2026. doi:10.3390/nu18101591

BibTeX
@article{Procopciuc2026,
  author = {Procopciuc, Lucia Maria and Hangan, Adrina Corina and Lucaciu, Roxana Liana},
  title = {Synbiotics as a Microbiome-Based Strategy in Colorectal Cancer},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18101591}
}
Kostenlos starten →